<DOC>
	<DOCNO>NCT02263378</DOCNO>
	<brief_summary>The purpose study evaluate whether supplement ellagic acid plus annona muricata combine , may modulate immune response high risk HPV infection . Sixty woman enrol randomize , control study , histological diagnosis L-SIL correlate high rish HPV type infection . Main outcome measure activation onco suppressor protein supplement secondary outcome clearance HPV infection treat group .</brief_summary>
	<brief_title>A New Supplement Immune Response HPV Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>woman high risk HPV infection histological diagnosis LSIL woman high risk HPV infection woman without histological diagnosis LSIL</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>HPV , L-SIL</keyword>
</DOC>